FindTrial
Sign In

Study on individualized medication for acute graft-versus-host disease after hematopoietic stem cell transplantation in children

Study on individualized medication for acute graft-versus-host disease after hematopoietic stem cell transplantation in children

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2000040561
Enrollment
Unknown
Registered
2020-12-02
Start date
2020-12-01
Completion date
Unknown
Last updated
2021-03-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

hematopoietic stem cell transplantation

Interventions

group of hematopoietic stem cell transplantation:none

Sponsors

Guangzhou Women and Children's Medical Center
Lead Sponsor

Eligibility

Sex/Gender
All
Age
0 Years to 18 Years

Inclusion criteria

Inclusion criteria: children (age<18 years) who underwent HSCT.

Exclusion criteria

Exclusion criteria: Patients with incomplete information.

Design outcomes

Primary

MeasureTime frame
Graft-versus host disease;—

Countries

China

Contacts

Public ContactMo Xiaolan

Guangzhou Women and Children's Medical Center

allenmor@163.com+86 18820095289

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 8, 2026